Management of corticosteroid-induced osteoporosis
Jonathan D. Adachi(St. Peter's Hospital), John Sibley(University of Saskatchewan), Anthony B. Hodsman(Western University), Louis‐Georges Ste‐Marie(Centre Hospitalier de l’Université de Montréal), David L. Kendler(University of British Columbia), Robert G. Josse(Western University), David Goltzman(Tel Aviv University), Jacques P. Brown(Centre hospitalier de l'Université Laval), David A. Hanley(The University of Sydney), George Ioannidis(McMaster University Medical Centre), Kerry Siminoski, Accles Pollock(University of Saskatchewan), Alan Tenenhouse(St. Vincent's Birmingham), E.A. Cowden(Dalhousie University), Kelly Davison(University of Saskatchewan), K. L. N. Blocka(University of Saskatchewan), Wojciech P. Olszynski(University of Saskatchewan)
Cited by 141
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
|The Lancet|2010|1.5k
Predictive Value of BMD for Hip and Other Fractures
|Journal of Bone and Mineral Research|2005|1.5k